Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

AFT.NZ

BUYGet insider-trade alerts

AFT Pharmaceuticals Limited · Healthcare · New Zealand · $218M · Avg Vol: $55K/d

78
StockRank
Q
62
V
36
M
70
P/E (TTM)
26.3x
ROE
13.7%
D/E
0.5x
Dividend %
0.7%
Director Trades · 180d
None in 180d →
Buybacks · 180d
None in 180d →
Loading...
PRICE (1Y)+6.1%
1.932.012.082.152.22May 15Jun 8Jun 26
SMA 50SMA 200
Close
$2.08
RSI (14)
27.7
52W High
$2.23
From 52W High
0.9%

SCORE BREAKDOWN

Quality
62
ROIC
16.0%87.1
ROE
13.7%79.7
GP/Assets
50.9%88.1
Op. Margin
14.1%73.7
FCF/Assets
-9.7%27.5
Piotroski
238.6
Int. Cover
10.9x61.7
D/E Ratio
0.50x32.3
Current Ratio
2.24x43.1
Value
36
P/E (TTM)
26.3x43.2
EV/EBITDA
17.2x35.9
P/FCF
—N/A
P/B
3.5x37.4
P/S
1.5x74.1
Div Yield
0.7%15.6
Momentum
70
52W High %
93%88.9
RS 6M
5%77.4
SMA 50/200
1.08x78.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+69%62.2
Q Growth
-19%24.3

FUNDAMENTALS

Market Cap
$218M
P/E (Forward)
15.5x
Gross Margin
43.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of AFT.NZ are excluded.

TickerCompanyMkt CapStockRankSignal
AFT.NZAFT Pharmaceuticals Limited(you)$218M78BUY
GXH.NZGreen Cross Health Limited$159M99STRONG BUY
ARX.AXAroa Biosurgery Limited$141M59HOLD
RAD.NZRadius Residential Care Limited$62M96STRONG BUY
OCA.NZOceania Healthcare Limited$304M37HOLD
PEB.NZPacific Edge Limited$210M29SELL
SUM.NZSummerset Group Holdings Limited$1.2B28SELL
FPH.AXFisher & Paykel Healthcare Corporation Limited$12.8B83STRONG BUY
RYM.NZRyman Healthcare Limited$1.3B25SELL

Peer medians: ROE 8.3% · P/E 14.0x · Gross margin 20.5%

AFT Pharmaceuticals Limited (AFT.NZ) — Stock Score Summary

AFT Pharmaceuticals Limited (AFT.NZ) has a MoatMap StockRank of 78/100 based on Quality (62/100), Value (36/100), and Momentum (70/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price$2.08
Market Cap$218M
P/E (TTM)26.29
P/E (Forward)15.54
Price/Book3.50
Return on Equity13.7%
Return on Invested Capital16.0%
Debt/Equity49.61
Gross Margin43.4%
Operating Margin14.1%
Revenue Growth15.2%
Dividend Yield0.7%
Free Cash Flow$-12M

AFT Pharmaceuticals Limited operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (New Zealand).

Frequently Asked Questions

What is AFT Pharmaceuticals Limited’s (AFT.NZ) StockRank?
MoatMap’s StockRank for AFT Pharmaceuticals Limited (AFT.NZ) is 78/100, with a Buy signal. It is a composite of Quality (62), Value (36), and Momentum (70) factor ranks across MoatMap’s 20,000+ stock universe.
Does AFT Pharmaceuticals Limited have an economic moat?
AFT Pharmaceuticals Limited (AFT.NZ) has a Quality factor score of 62/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is AFT Pharmaceuticals Limited a buy, hold, or sell?
MoatMap’s current signal for AFT Pharmaceuticals Limited (AFT.NZ) is Buy, based on a StockRank of 78/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is AFT Pharmaceuticals Limited in?
AFT Pharmaceuticals Limited (AFT.NZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (New Zealand).
Browse all ranked stocksAFT.NZ deep dive reportAI ChampionsHow we score stocksSense-check another stock